IT1248056B - Sostanza proteica e procedimento per la sua preparazione - Google Patents

Sostanza proteica e procedimento per la sua preparazione

Info

Publication number
IT1248056B
IT1248056B ITMI911634A ITMI911634A IT1248056B IT 1248056 B IT1248056 B IT 1248056B IT MI911634 A ITMI911634 A IT MI911634A IT MI911634 A ITMI911634 A IT MI911634A IT 1248056 B IT1248056 B IT 1248056B
Authority
IT
Italy
Prior art keywords
procedure
preparation
protein substance
protein
substance
Prior art date
Application number
ITMI911634A
Other languages
English (en)
Inventor
Alberto Mantovani
Barbara Bottazzi
Riccardo Bertini
Original Assignee
Dompe Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Spa filed Critical Dompe Spa
Priority to ITMI911634A priority Critical patent/IT1248056B/it
Publication of ITMI911634A0 publication Critical patent/ITMI911634A0/it
Priority to JP4510719A priority patent/JPH06510424A/ja
Priority to PCT/EP1992/001298 priority patent/WO1992022664A1/en
Priority to EP92911651A priority patent/EP0592464A1/en
Priority to AU19013/92A priority patent/AU1901392A/en
Publication of ITMI911634A1 publication Critical patent/ITMI911634A1/it
Application granted granted Critical
Publication of IT1248056B publication Critical patent/IT1248056B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8146Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Viene descritta una sostanza proteica avente peso molecolare di circa 1OKDa la quale è prodotta da cellule di carcinoma umano dell'ovaio e che è dotata di attività chemiotattica sui monociti.
ITMI911634A 1991-06-13 1991-06-13 Sostanza proteica e procedimento per la sua preparazione IT1248056B (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ITMI911634A IT1248056B (it) 1991-06-13 1991-06-13 Sostanza proteica e procedimento per la sua preparazione
JP4510719A JPH06510424A (ja) 1991-06-13 1992-06-10 走化因子
PCT/EP1992/001298 WO1992022664A1 (en) 1991-06-13 1992-06-10 Chemotactic factor
EP92911651A EP0592464A1 (en) 1991-06-13 1992-06-10 Chemotactic factor
AU19013/92A AU1901392A (en) 1991-06-13 1992-06-10 Chemotactic factor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911634A IT1248056B (it) 1991-06-13 1991-06-13 Sostanza proteica e procedimento per la sua preparazione

Publications (3)

Publication Number Publication Date
ITMI911634A0 ITMI911634A0 (it) 1991-06-13
ITMI911634A1 ITMI911634A1 (it) 1992-12-13
IT1248056B true IT1248056B (it) 1995-01-05

Family

ID=11360114

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI911634A IT1248056B (it) 1991-06-13 1991-06-13 Sostanza proteica e procedimento per la sua preparazione

Country Status (5)

Country Link
EP (1) EP0592464A1 (it)
JP (1) JPH06510424A (it)
AU (1) AU1901392A (it)
IT (1) IT1248056B (it)
WO (1) WO1992022664A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994021809A1 (en) * 1993-03-15 1994-09-29 Institute Of Cytosignal Research, Inc. Monocyte or macrophage migration factor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0189784B1 (en) * 1985-01-18 1989-11-08 G.D. Searle & Co. Human natural inhibitor of collagenases

Also Published As

Publication number Publication date
WO1992022664A1 (en) 1992-12-23
EP0592464A1 (en) 1994-04-20
ITMI911634A0 (it) 1991-06-13
AU1901392A (en) 1993-01-12
ITMI911634A1 (it) 1992-12-13
JPH06510424A (ja) 1994-11-24

Similar Documents

Publication Publication Date Title
ES2058796T3 (es) Aislamiento y elucidacion estructural del depsipeptido citostatico lineal dolastatina 15.
DK1288224T3 (da) Terapeutiske peptidderivater
IT1231434B (it) Composizione farmaceutica endovenosa e procedimento per la sua preparazione.
CL2009002139A1 (es) Peptido sintetico que comprende la secuencia sec id no:6 y sec id no:7 de la proteina gp41 del virus vih con actividad antiretroviral.
GR3030811T3 (en) Proteins produced by human lymphocytes, dna sequence coding these proteins, and pharmaceutical and biological uses thereof
MX9203439A (es) Una citocina mamifera, il-11
ATE73321T1 (de) Zusammensetzung mit verzoegerter abgabe.
DE3689246D1 (de) Physiologisch aktives Polypeptid BUF-3.
DE3875108T2 (de) Physiologisch aktives polypeptid und pharmazeutische komposition.
ES2127940T3 (es) Bloqueo de la adhesion de germenes a celulas humanas.
ES2110009T3 (es) Derivados de la estreptolisina o.
GR880100775A (el) Παράγοντας ενεργοποιήσεως ουδετεροφίλων.
FI893681A (fi) N-2,3-butadienyltri- och tetra-aminoalkanderivat.
ES2099274T3 (es) Derivados de estreptolisina o.
GB9311454D0 (en) Pharmaceutical compositions
IT1248056B (it) Sostanza proteica e procedimento per la sua preparazione
IT8819791A0 (it) Peptidi ad attivita' farmaceutica.
FR2632525B1 (fr) Application therapeutique de la myeloperoxydase humaine
IT8423896A0 (it) Diacilderivati della glicerilfosforilcolina ad attivita' terapeutica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
IT8026233A0 (it) Derivato della n-acetil-cisteina ad attivita' terapeutica, procedimento per la sua preparazione e relative composizioni farmaceutiche.
IT207326Z2 (it) Dispositivo autobloccante per regolare, attraverso i braccioli, l'inclinazione dello schienale di poltrone a piu' posizioni d'impiego.
ITMI911147A0 (it) Composto ad attivita' terapeutica,sua preparazione e composizioni farmaceutiche che lo contengono
IT1233005B (it) Anticorpo umano monoclonale, composizione terapeutica che lo contiene linea cellulare capace di produrre l'anticorpo, procedimento per la sua produzione
IT1209323B (it) Sostanza biologicamente attiva, conproprieta'immuno-stimolanti,sua preparazione e medicamenti che la con tengono per aumentare la resistenza verso le infezioni
ES2096081T3 (es) Utilizacion de interleuquina 10 para la preparacion de medicamentos con una actividad inhibidora de tumores.

Legal Events

Date Code Title Description
0001 Granted